Callos Andrew bought CYTK

January 5, 2026 · Form 4 insider transaction

Callos Andrew bought 15,000 shares of Cytokinetics, Incorporated at $23.26 per share, a transaction worth $348.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.